ConductScience.org, home

Paper14241

Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.

Aranda JV and 3 others. J Pediatr, 1977. Cited by 264 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. Papers, record 14241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14241

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.
PubMed
Journal
J Pediatr
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
264
iCite
Relative citation ratio, by iCite
11.2
iCite
Revised in PubMed
2022-03-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aranda JVJ V
2Gorman WW
3Bergsteinsson HH
4Gunn TT

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApneaMajor topic
CaffeineMajor topic
Infant, Low Birth WeightMajor topic
Infant, Newborn, DiseasesMajor topic
Carbon Dioxide
Drug Evaluation
Humans
Hydrogen-Ion Concentration
Infant, Newborn

Source PubMed

Cited by67

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 264 citations.

PMIDTitleJournalYearIn PapersSource
42,640,008Advancing Neonatal Drug Development Through Industry-Academic Collaboration.J Clin Pharmacol2026https://conductscience.org/library/papers/42640008PubMed
42,244,880Developmental age and clinical illness drive in vivo variability of CYP1A2 ontogeny and caffeine metabolism in preterm neonates.Front Pharmacol2026https://conductscience.org/library/papers/42244880PubMed
41,965,906Caffeine prevents airway hyperreactivity in a neonatal mouse model of continuous positive airway pressure.Pediatr Res2026https://conductscience.org/library/papers/41965906PubMed
41,540,197Putative mechanisms of caffeine as a neuroprotectant in preterm infants.Pediatr Res2026https://conductscience.org/library/papers/41540197PubMed
41,165,563Caffeine-associated reduction in patent ductus arteriosus is mediated in part by adenosine receptor antagonism.Am J Physiol Heart Circ Physiol2025https://conductscience.org/library/papers/41165563PubMed
41,152,486Apnoea duration and changes in cardiorespiratory and cerebrovascular responses in preterm neonates: a systematic review and meta-analysis.Pediatr Res2026https://conductscience.org/library/papers/41152486PubMed
41,020,198Caffeine Therapy Reduces Severe Retinopathy of Prematurity in Neonates with Gestational Age between 23 and 28 Weeks.Ophthalmol Sci2026https://conductscience.org/library/papers/41020198PubMed
40,620,533What is the Role of Caffeine in the Management of Preterm Infants?Curr Treat Options Pediatr2025https://conductscience.org/library/papers/40620533PubMed
40,083,438Caffeine use in preterm neonates: national insights into Turkish NICU practices.Front Pediatr2025https://conductscience.org/library/papers/40083438PubMed
39,334,735Caffeine: The Story beyond Oxygen-Induced Lung and Brain Injury in Neonatal Animal Models-A Narrative Review.Antioxidants (Basel)2024https://conductscience.org/library/papers/39334735PubMed
39,045,901Strategies for cessation of caffeine administration in preterm infants.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/39045901PubMed
38,643,263Caffeine: how early is too early?Pediatr Res2024https://conductscience.org/library/papers/38643263PubMed
38,553,606Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis.J Perinatol2024https://conductscience.org/library/papers/38553606PubMed
38,470,639The Babyccino: The Role of Caffeine in the Prevention of Acute Kidney Injury in Neonates-A Literature Review.Healthcare (Basel)2024https://conductscience.org/library/papers/38470639PubMed
38,429,570Caffeine pharmacokinetics following umbilical vein injection during delayed cord clamping in preterm lambs.Pediatr Res2024https://conductscience.org/library/papers/38429570PubMed
37,718,322What do we know about the sleep effects of caffeine used to treat apnoea of prematurity? A systematic review of the literature.Mol Cell Pediatr2023https://conductscience.org/library/papers/37718322PubMed
35,692,738Is Early Preventive Caffeine Safe and Effective in Premature Neonates? A Clinical Trial.Int J Pediatr2022https://conductscience.org/library/papers/35692738PubMed
35,356,441Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?Front Pediatr2022https://conductscience.org/library/papers/35356441PubMed
35,351,252Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study.Zhongguo Dang Dai Er Ke Za Zhi2022https://conductscience.org/library/papers/35351252PubMed
34,381,359Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors.Front Pharmacol2021https://conductscience.org/library/papers/34381359PubMed

See all 67 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14241

GET https://conductscience.org/api/papers/v1/14241/cited_by?page=2